CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Square Pharmaceuticals PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Square Pharmaceuticals PLC
SQUARE Centre
48 Mohakhali Commercial Area,
Phone: +880 29859007p:+880 29859007 DHAKA, 1212  Bangladesh Ticker: SQURPHARMASQURPHARMA
Business Summary
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical manufacturer and exporter. Its core business activities include the manufacture and distribution of generic pharmaceutical products, basic chemical products, and animal health products. The Company operates in one segment: the business of developing, manufacturing, and marketing drugs for healthcare for all living species. It is also involved in the distribution of crop care products. The Company offers its products in several categories, including products listed by trade name, by therapeutic class, and by generic name. In addition to conventional pharmaceuticals, it also offers products under the Herbal & Nutraceuticals category, as well as AgroVet & Pesticides, which cover veterinary and agricultural chemical products. The Company’s manufacturing facilities are located in Pabna and Dhaka, Bangladesh. Its subsidiaries include Square Lifesciences Ltd., Square Pharmaceuticals Kenya EPZ Ltd., and Samson Pharma Inc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20256/30/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research
2879 Pesticides and agricultural chemicals, not elsewhere classified
2048 Prepared feeds and feed ingredients for animals and fowls, except dog and cat
5122 Drugs, drug proprietaries, and druggists' sundries
5191 Farm supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Samuel S.Chowdhury 1/1/2012 1/1/2012
Vice Chairman of the Board RatnaPatra 1/5/2012 1/1/2007
Chief Financial Officer Muhammad ZahangirAlam
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 12,453 (As of 6/30/2024)
Outstanding Shares: 886,451,010 (As of 3/31/2025)
Shareholders: 68,080
Stock Exchange: DSE
Fax Number: +880 28834941


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 12, 2025